Ranked after the close on October 30, 2026
Diagnostics & Research stocks
Diagnostics & Research ranks #2 of 140 industry groups, one of the market's strongest groups, with a median 6-month return of +51% across its 30 US stocks above $1B (sector: Healthcare). CDNA is in today's top 50 leaders.
#2group rank of 140
+51%median, 6 months
30stocks above $1B
1in the top 50
Diagnostics & Research stocks ranked
| # | Stock | Market cap | Off high | Comp | EPS | RS |
|---|---|---|---|---|---|---|
| 1 | CDNA Top 50CareDx, Inc. | $4.6B | 3.8% | |||
| 2 | MEDPMedpace Holdings, Inc. | $18.2B | 6.0% | |||
| 3 | VCYTVeracyte, Inc. | $4.0B | 17.9% | |||
| 4 | NTRANatera, Inc. | $59.7B | 5.3% | |||
| 5 | ILMNIllumina, Inc. | $35.7B | 23.7% | |||
| 6 | GRALGRAIL, Inc. | $6.4B | 13.8% | |||
| 7 | OPKOpko Health, Inc. | $1.2B | 6.2% | |||
| 8 | SHCSotera Health Company | $5.2B | 8.6% | |||
| 9 | ICLRICON plc | $15.8B | 3.5% | |||
| 10 | AAgilent Technologies, Inc. | $49.3B | 4.4% | |||
| 11 | DGXQuest Diagnostics Incorporated | $27.8B | 2.0% | |||
| 12 | TMOThermo Fisher Scientific Inc | $258.2B | 2.1% | |||
| 13 | BLLNBillionToOne, Inc. | $5.3B | 24.7% | |||
| 14 | IQVIQVIA Holdings, Inc. | $44.1B | 6.0% | |||
| 15 | MTDMettler-Toledo International, I | $33.6B | 3.1% | |||
| 16 | NEONeoGenomics, Inc. | $2.2B | 13.7% | |||
| 17 | DHRDanaher Corporation | $163.3B | 4.4% | |||
| 18 | GHGuardant Health, Inc. | $24.0B | 6.4% | |||
| 19 | LHLabcorp Holdings Inc. | $29.3B | 2.6% | |||
| 20 | RVTYRevvity, Inc. | $17.5B | 7.1% | |||
| 21 | WATWaters Corporation | $45.4B | 4.1% | |||
| 22 | PSNLPersonalis, Inc. | $1.7B | 16.3% | |||
| 23 | QGENQiagen N.V. | $10.4B | 13.1% | |||
| 24 | ADPTAdaptive Biotechnologies Corpor | $4.3B | 13.3% | |||
| 25 | CRLCharles River Laboratories Inte | $17.2B | 5.3% | |||
| 26 | IDXXIDEXX Laboratories, Inc. | $43.5B | 28.4% | |||
| 27 | CSTLCastle Biosciences, Inc. | $1.1B | 16.1% | |||
| 28 | RDNTRadNet, Inc. | $5.8B | 14.4% | |||
| 29 | WGSGeneDx Holdings Corp. | $2.1B | 59.6% | |||
| 30 | FRNMFreenome, Inc. | $1.3B | 28.7% |
In order of their Comp rating. The ratings themselves, and the same day's ranking, are for members. Sign in or start for €6.99 a month.
See every rating for €6.99 a month